首页> 外文期刊>Behavioural Brain Research: An International Journal >The rate of behavioral tolerance development to repeated lipopolysaccharide treatments depends upon the time of injection during the light-dark cycle: a multivariable examination of locomotor activity.
【24h】

The rate of behavioral tolerance development to repeated lipopolysaccharide treatments depends upon the time of injection during the light-dark cycle: a multivariable examination of locomotor activity.

机译:重复性脂多糖治疗对行为耐受的发展速度取决于在明暗周期内的注射时间:运动活动的多变量检查。

获取原文
获取原文并翻译 | 示例
           

摘要

Recent evidence suggests that sickness behaviors following lipopolysaccharide (LPS)-treatment may be modulated by environmental factors such as the light-dark (LD) cycle. The present study characterized LPS-induced hypoactivity and behavioral tolerance development across individual phases of the light-dark cycle and the transitions between phases. On days 1, 4 and 7, male rats were treated with LPS (200microg/kg i.p.) or saline 30min prior to the onset of either the dark period (dark-tested group) or the light period (light-tested group). Following treatment, rats were placed in non-novel automated open-fields where various aspects of locomotor activity were monitored for 16h. On day 1, LPS-treated rats in both the dark and light tested groups showed significant hypoactivity. However, temporal differences in the onset of hypoactivity were observed between the groups. In dark tested animals significant hypoactivity started 60min after LPS treatment and continued until the light period when hypoactivity was diminished. In contrast, the light tested LPS-treated animals did not exhibit a prolonged period of hypoactivity until the transition between the light and dark periods, 750min following LPS injection. On days 4 and 7, light tested animals showed complete tolerance to LPS as evidenced by the absence of significant activity reductions, whereas dark tested animals continued to show significant periods of hypoactivity. These results indicate that there are day-night differences in both the initial LPS-induced hypoactivity response as well as behavioral tolerance development. The rate of tolerance development to LPS may be a critical factor to survival and the prevention of sepsis, as organisms are repeatedly exposed to pathogens across the life cycle.
机译:最近的证据表明,脂多糖(LPS)处理后的疾病行为可能受到环境因素(例如,明暗(LD)周期)的调节。本研究的特点是LPS诱导的机能减退和行为耐受性发展跨越明暗周期的各个阶段以及阶段之间的过渡。在第1天,第4天和第7天,在黑暗期(黑暗测试组)或光照期(光照测试组)发作前30分钟,用LPS(200microg / kg i.p.)或生理盐水治疗雄性大鼠。治疗后,将大鼠置于非新颖的开放场地中,在那里监测运动活动的各个方面16小时。在第1天,在黑暗和明亮测试组中,LPS处理的大鼠均表现出明显的机能减退。然而,在两组之间观察到机能减退发作的时间差异。在黑暗测试的动物中,LPS处理后60分钟开始出现明显的机能减退,并持续到轻度期,此时机能减退减弱。相反,在LPS注射后750分钟,经过光照测试的经LPS处理的动物直到长时间在亮与暗之间过渡之前,没有表现出延长的机能减退。在第4天和第7天,光照测试的动物表现出对LPS的完全耐受性,这由缺乏明显的活性降低所证明,而黑暗测试的动物则继续表现出明显的活动不足。这些结果表明,最初的LPS诱导的机能减退反应以及行为耐受性的发展都存在昼夜差异。对LPS的耐受性发展速度可能是存活和预防败血症的关键因素,因为生物在整个生命周期中反复接触病原体。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号